FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: Massachusetts is a significant hub for biotechnology, and the potential approval of Moderna's mRNA flu vaccine could have a substantial impact on the state's life sciences industry, including research, development, and manufacturing sectors. This decision could influence investment and job growth within the state's robust biotech ecosystem.

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.